APA   Click to copy
Obara, H., Tatara, Y., Monzen, S., Murakami, S., Yamamoto, H., Kimura, N., … Hatayama, Y. (2024). Exploring predictive molecules of acute adverse events in response to volumetric‑modulated arc therapy for prostate cancer using urinary metabolites. Molecular and Clinical Oncology, 21, 62. https://doi.org/10.3892/mco.2024.2760

Chicago/Turabian   Click to copy
Obara, H., Y. Tatara, S. Monzen, S. Murakami, H. Yamamoto, N. Kimura, M. Suzuki, F. Komai, M. Narita, and Y. Hatayama. “Exploring Predictive Molecules of Acute Adverse Events in Response to Volumetric‑Modulated Arc Therapy for Prostate Cancer Using Urinary Metabolites.” Molecular and Clinical Oncology 21 (2024): 62.

MLA   Click to copy
Obara, H., et al. “Exploring Predictive Molecules of Acute Adverse Events in Response to Volumetric‑Modulated Arc Therapy for Prostate Cancer Using Urinary Metabolites.” Molecular and Clinical Oncology, vol. 21, 2024, p. 62, doi:10.3892/mco.2024.2760.

@article{obara2024a,
  title = {Exploring predictive molecules of acute adverse events in response to volumetric‑modulated arc therapy for prostate cancer using urinary metabolites},
  year = {2024},
  journal = {Molecular and Clinical Oncology},
  pages = {62},
  volume = {21},
  doi = {10.3892/mco.2024.2760},
  author = {Obara, H. and Tatara, Y. and Monzen, S. and Murakami, S. and Yamamoto, H. and Kimura, N. and Suzuki, M. and Komai, F. and Narita, M. and Hatayama, Y.}
}